Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
69
CNVS Quote, Financials, Valuation and Earnings
Last price:
$6.51
Seasonality move
:
-4.71%
Day range:
$6.33 - $6.74
52-week range:
$0.72 - $7.39
Dividend yield:
0%
P/E ratio:
72.89x
P/S ratio:
1.42x
P/B ratio:
3.19x
Volume:
214.4K
Avg. volume:
445.4K
1-year change:
637.08%
Market cap:
$112.2M
Revenue:
$78.2M
EPS (TTM):
-$1.14
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $31.4M | $56.1M | $68M | $49.1M | $78.2M | |
| Revenue Growth (YoY) | -20.04% | 78.41% | 21.36% | -27.78% | 59.13% | |
| Cost of Revenues | $16.1M | $20.9M | $36.4M | $19.1M | $38.8M | |
| Gross Profit | $15.3M | $35.2M | $31.7M | $30M | $39.4M | |
| Gross Profit Margin | 48.75% | 62.73% | 46.54% | 61.06% | 50.4% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $21.9M | $26.6M | $30.5M | $23M | $22.5M | |
| Other Inc / (Exp) | -$45.7M | $796K | -$1.8M | -$18.5M | $311K | |
| Operating Expenses | $28.8M | $34.1M | $38.1M | $31.7M | $31.5M | |
| Operating Income | -$13.5M | $1M | -$6.4M | -$1.7M | $7.9M | |
| Net Interest Expenses | $4.1M | $356K | $1.3M | $1.1M | $4.4M | |
| EBT. Incl. Unusual Items | -$63.2M | $1.5M | -$9.6M | -$21.3M | $3.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$315K | -$788K | $119K | $10K | $106K | |
| Net Income to Company | -$62.9M | $2.3M | -$9.7M | -$21.3M | $3.8M | |
| Minority Interest in Earnings | $85K | -$59K | -$39K | -$142K | -$162K | |
| Net Income to Common Excl Extra Items | -$62.8M | $2.2M | -$9.7M | -$21.4M | $3.6M | |
| Basic EPS (Cont. Ops) | -$9.80 | $0.21 | -$1.13 | -$1.78 | $0.18 | |
| Diluted EPS (Cont. Ops) | -$9.80 | $0.20 | -$1.13 | -$1.78 | $0.16 | |
| Weighted Average Basic Share | $6.4M | $8.5M | $8.9M | $12.3M | $15.8M | |
| Weighted Average Diluted Share | $6.4M | $8.7M | $8.9M | $12.3M | $17.8M | |
| EBITDA | -$52.2M | $6.4M | -$4.5M | -$16.4M | $12M | |
| EBIT | -$59.1M | $1.8M | -$8.3M | -$20.2M | $8.2M | |
| Revenue (Reported) | $31.4M | $56.1M | $68M | $49.1M | $78.2M | |
| Operating Income (Reported) | -$13.5M | $1M | -$6.4M | -$1.7M | $7.9M | |
| Operating Income (Adjusted) | -$59.1M | $1.8M | -$8.3M | -$20.2M | $8.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.3M | $16.9M | $12.5M | $9.9M | $15.6M | |
| Revenue Growth (YoY) | 6.85% | 103.9% | -25.54% | -21.4% | 57.91% | |
| Cost of Revenues | $4.7M | $6.5M | $6.5M | $2M | $7M | |
| Gross Profit | $3.6M | $10.4M | $6M | $7.8M | $8.5M | |
| Gross Profit Margin | 43.03% | 61.6% | 48.16% | 79.38% | 54.81% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $6.5M | $7.5M | $5.1M | $5.4M | $3.7M | |
| Other Inc / (Exp) | -$1.9M | -$2.9M | $69K | -$14.4M | $73K | |
| Operating Expenses | $8M | $9.9M | $8.7M | $7.8M | $6.4M | |
| Operating Income | -$4.4M | $447K | -$2.6M | $29K | $2.1M | |
| Net Interest Expenses | $618K | $79K | $410K | $285K | $1.3M | |
| EBT. Incl. Unusual Items | -$6.9M | -$2.5M | -$3M | -$14.7M | $945K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$134K | -$212K | $119K | -$2K | $87K | |
| Net Income to Company | -$6.8M | -$2.3M | -$3.1M | -$14.7M | $858K | |
| Minority Interest in Earnings | $25K | -$82K | -$4K | -$48K | -$7K | |
| Net Income to Common Excl Extra Items | -$6.8M | -$2.4M | -$3.1M | -$14.7M | $851K | |
| Basic EPS (Cont. Ops) | -- | -$0.40 | -$0.35 | -$1.19 | $0.04 | |
| Diluted EPS (Cont. Ops) | -- | -$0.40 | -$0.35 | -$1.19 | $0.04 | |
| Weighted Average Basic Share | $8.3M | $8.7M | $9M | $14M | $16M | |
| Weighted Average Diluted Share | $8.3M | $8.8M | $9M | $14M | $18.6M | |
| EBITDA | -$4.8M | -$1.6M | -$1.6M | -$13.4M | $3.2M | |
| EBIT | -$6.3M | -$2.5M | -$2.5M | -$14.4M | $2.2M | |
| Revenue (Reported) | $8.3M | $16.9M | $12.5M | $9.9M | $15.6M | |
| Operating Income (Reported) | -$4.4M | $447K | -$2.6M | $29K | $2.1M | |
| Operating Income (Adjusted) | -$6.3M | -$2.5M | -$2.5M | -$14.4M | $2.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $31.4M | $56.1M | $68M | $49.1M | $78.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $16.1M | $20.9M | $36.4M | $19.1M | $38.8M | |
| Gross Profit | $15.3M | $35.2M | $31.7M | $30M | $39.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $21.9M | $27.9M | $30.1M | $23M | $22.5M | |
| Other Inc / (Exp) | -$45.9M | $725K | -$1.8M | -$18.5M | $313K | |
| Operating Expenses | $28.6M | $34M | $38.1M | $31.7M | $31.5M | |
| Operating Income | -$13.3M | $1.1M | -$6.4M | -$1.7M | $7.9M | |
| Net Interest Expenses | $4.1M | $356K | $1.3M | $1.1M | $4.4M | |
| EBT. Incl. Unusual Items | -$63.2M | $1.5M | -$9.6M | -$21.3M | $3.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$315K | -$788K | $119K | $10K | $106K | |
| Net Income to Company | -$62.9M | $2.3M | -$9.7M | -$21.3M | $3.8M | |
| Minority Interest in Earnings | $85K | -$59K | -$39K | -$143K | -$162K | |
| Net Income to Common Excl Extra Items | -$62.8M | $2.2M | -$9.7M | -$21.4M | $3.6M | |
| Basic EPS (Cont. Ops) | -$10.20 | $0.11 | -$1.14 | -$1.82 | $0.13 | |
| Diluted EPS (Cont. Ops) | -$10.20 | $0.11 | -$1.14 | -$1.82 | $0.09 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$52.2M | $6.4M | -$4.5M | -$16.4M | $12M | |
| EBIT | -$59.1M | $1.8M | -$8.3M | -$20.2M | $8.2M | |
| Revenue (Reported) | $31.4M | $56.1M | $68M | $49.1M | $78.2M | |
| Operating Income (Reported) | -$13.3M | $1.1M | -$6.4M | -$1.7M | $7.9M | |
| Operating Income (Adjusted) | -$59.1M | $1.8M | -$8.3M | -$20.2M | $8.2M | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $56.1M | $68M | $49.1M | $78.2M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $20.9M | $36.4M | $19.1M | $38.8M | -- | |
| Gross Profit | $35.2M | $31.7M | $30M | $39.4M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $27.9M | $30.1M | $23M | $22.5M | -- | |
| Other Inc / (Exp) | $725K | -$1.8M | -$18.5M | $313K | -- | |
| Operating Expenses | $34M | $38.1M | $31.7M | $31.5M | -- | |
| Operating Income | $1.1M | -$6.4M | -$1.7M | $7.9M | -- | |
| Net Interest Expenses | $356K | $1.3M | $1.1M | $4.4M | -- | |
| EBT. Incl. Unusual Items | $1.5M | -$9.6M | -$21.3M | $3.9M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$788K | $119K | $10K | $106K | -- | |
| Net Income to Company | $2.3M | -$9.7M | -$21.3M | $3.8M | -- | |
| Minority Interest in Earnings | -$59K | -$39K | -$143K | -$162K | -- | |
| Net Income to Common Excl Extra Items | $2.2M | -$9.7M | -$21.4M | $3.6M | -- | |
| Basic EPS (Cont. Ops) | $0.11 | -$1.14 | -$1.82 | $0.13 | -- | |
| Diluted EPS (Cont. Ops) | $0.11 | -$1.14 | -$1.82 | $0.09 | -- | |
| Weighted Average Basic Share | $34.2M | $35.6M | $49.1M | $63.3M | -- | |
| Weighted Average Diluted Share | $34.4M | $35.6M | $49.1M | $67.8M | -- | |
| EBITDA | $6.4M | -$4.5M | -$16.4M | $12M | -- | |
| EBIT | $1.8M | -$8.3M | -$20.2M | $8.2M | -- | |
| Revenue (Reported) | $56.1M | $68M | $49.1M | $78.2M | -- | |
| Operating Income (Reported) | $1.1M | -$6.4M | -$1.7M | $7.9M | -- | |
| Operating Income (Adjusted) | $1.8M | -$8.3M | -$20.2M | $8.2M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $16.8M | $13.1M | $7.2M | $5.2M | $13.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $21.1M | $30.8M | $20.8M | $15.1M | $15.8M | |
| Inventory | $166K | $116K | -- | -- | -- | |
| Prepaid Expenses | $2.7M | $5M | $3.7M | $9.3M | $6.7M | |
| Other Current Assets | -- | -- | $1.7M | $1.4M | $1.6M | |
| Total Current Assets | $43.1M | $52.2M | $37.6M | $32.7M | $38.1M | |
| Property Plant And Equipment | $3.6M | $2M | $1.8M | $2.3M | $2.9M | |
| Long-Term Investments | $6.4M | $7M | $5.2M | $362K | -- | |
| Goodwill | $8.7M | $21.1M | $20.8M | $6.8M | $6.8M | |
| Other Intangibles | $9.9M | $20M | $19.9M | $18.3M | $18.2M | |
| Other Long-Term Assets | $3.7M | $2.3M | $1.3M | $1.7M | $2.5M | |
| Total Assets | $75.4M | $104.6M | $88M | $64.4M | $72.5M | |
| Accounts Payable | $30.1M | $34.2M | $15M | $5.8M | $7.3M | |
| Accrued Expenses | $3.1M | $3.9M | $3.8M | $4M | $5.9M | |
| Current Portion Of Long-Term Debt | $9.7M | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $87K | $258K | $418K | $401K | $187K | |
| Other Current Liabilities | -- | $1.1M | $1.4M | $180K | -- | |
| Total Current Liabilities | $57.4M | $57M | $45.3M | $31.2M | $34.4M | |
| Long-Term Debt | $2.2M | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $59.6M | $63.7M | $48.9M | $32.2M | $34.7M | |
| Common Stock | $3.7M | $3.7M | $3.7M | $3.8M | $3.8M | |
| Other Common Equity Adj | -$68K | -$163K | -$402K | -$345K | -$305K | |
| Common Equity | $13.7M | $38.7M | $36.8M | $29.7M | $35.2M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$1.4M | -$1.3M | -$1.3M | -$1.1M | -$960K | |
| Total Equity | $15.9M | $41M | $39.1M | $32.2M | $37.8M | |
| Total Liabilities and Equity | $75.4M | $104.6M | $88M | $64.4M | $72.5M | |
| Cash and Short Terms | $16.8M | $13.1M | $7.2M | $5.2M | $13.9M | |
| Total Debt | $11.9M | -- | $4.9M | $6.3M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $16.8M | $13.1M | $7.2M | $5.2M | $13.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $21.1M | $30.8M | $20.8M | $15.1M | $15.8M | |
| Inventory | $166K | $116K | -- | -- | -- | |
| Prepaid Expenses | $2.7M | $5M | $3.7M | $9.3M | $6.7M | |
| Other Current Assets | -- | -- | $1.7M | $1.4M | $1.6M | |
| Total Current Assets | $43.1M | $52.2M | $37.6M | $32.7M | $38.1M | |
| Property Plant And Equipment | $3.6M | $2M | $1.8M | $2.3M | $2.9M | |
| Long-Term Investments | $6.4M | $7M | $5.2M | $362K | -- | |
| Goodwill | $8.7M | $21.1M | $20.8M | $6.8M | $6.8M | |
| Other Intangibles | $9.9M | $20M | $19.9M | $18.3M | $18.2M | |
| Other Long-Term Assets | $3.7M | $2.3M | $1.3M | $1.7M | $2.5M | |
| Total Assets | $75.4M | $104.6M | $88M | $64.4M | $72.5M | |
| Accounts Payable | $30.1M | $34.2M | $15M | $5.8M | $7.3M | |
| Accrued Expenses | $3.1M | $3.9M | $3.8M | $4M | $5.9M | |
| Current Portion Of Long-Term Debt | $9.7M | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $87K | $258K | $418K | $401K | $187K | |
| Other Current Liabilities | -- | $1.1M | $1.4M | $180K | -- | |
| Total Current Liabilities | $57.4M | $57M | $45.3M | $31.2M | $34.4M | |
| Long-Term Debt | $2.2M | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $59.6M | $63.7M | $48.9M | $32.2M | $34.7M | |
| Common Stock | $3.7M | $3.7M | $3.7M | $3.8M | $3.8M | |
| Other Common Equity Adj | -$68K | -$163K | -$402K | -$345K | -$305K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$1.4M | -$1.3M | -$1.3M | -$1.1M | -$960K | |
| Total Equity | $15.9M | $41M | $39.1M | $32.2M | $37.8M | |
| Total Liabilities and Equity | $75.4M | $104.6M | $88M | $64.4M | $72.5M | |
| Cash and Short Terms | $16.8M | $13.1M | $7.2M | $5.2M | $13.9M | |
| Total Debt | $11.9M | -- | $4.9M | $6.3M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$62.9M | $2.3M | -$9.7M | -$21.3M | $3.8M | |
| Depreciation & Amoritzation | $6.9M | $4.6M | $3.8M | $3.8M | $3.8M | |
| Stock-Based Compensation | $2.9M | $5.5M | $4.5M | $1.4M | $1.9M | |
| Change in Accounts Receivable | $14.3M | -$9.1M | $10.3M | $7.6M | -$619K | |
| Change in Inventories | $406K | $50K | -- | -- | -- | |
| Cash From Operations | -$20M | $4.9M | -$8.8M | -$10.6M | $17.4M | |
| Capital Expenditures | $2.6M | $641K | $1.3M | $1.1M | $1.2M | |
| Cash Acquisitions | $815K | -$11.7M | -- | -- | -- | |
| Cash From Investing | -$1.7M | -$12.3M | -$1.3M | -$531K | -$635K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.2M | -- | $31M | $44M | $67M | |
| Long-Term Debt Repaid | -$20.5M | -$9.7M | -$26M | -$42.6M | -$73.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$215K | |
| Other Financing Activities | -- | -- | -$842K | -$769K | -$1.3M | |
| Cash From Financing | $24.3M | $2.6M | $4.2M | $9.1M | -$8M | |
| Beginning Cash (CF) | $15.3M | $17.8M | $13.1M | $7.2M | $5.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.6M | -$4.8M | -$5.9M | -$2M | $8.8M | |
| Ending Cash (CF) | $17.8M | $13.1M | $7.2M | $5.2M | $13.9M | |
| Levered Free Cash Flow | -$22.6M | $4.2M | -$10.1M | -$11.7M | $16.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.8M | -$2.3M | -$3.1M | -$14.7M | $858K | |
| Depreciation & Amoritzation | $1.5M | $903K | $921K | $984K | $1M | |
| Stock-Based Compensation | $720K | $2.2M | $615K | $347K | $462K | |
| Change in Accounts Receivable | $5.6M | $553K | $7.3M | $4.2M | $18.2M | |
| Change in Inventories | $47K | $50K | -- | -- | -- | |
| Cash From Operations | -$3.2M | $133K | -$895K | -$1.3M | $12.4M | |
| Capital Expenditures | $1.5M | $349K | $842K | $428K | $67K | |
| Cash Acquisitions | $815K | -$6.9M | -- | -$159K | -$449K | |
| Cash From Investing | -$1.6M | -$7.3M | -$842K | -$49K | $20K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $11.6M | $15.4M | $16.5M | |
| Long-Term Debt Repaid | $1.8M | -- | -$11.6M | -$14M | -$20.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | $94K | -$383K | -$596K | |
| Cash From Financing | -$4.5M | -- | $94K | $982K | -$4.6M | |
| Beginning Cash (CF) | $27.2M | $20.2M | $8.8M | $5.5M | $6.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$9.4M | -$7.1M | -$1.6M | -$372K | $7.9M | |
| Ending Cash (CF) | $17.8M | $13.1M | $7.2M | $5.2M | $13.9M | |
| Levered Free Cash Flow | -$4.8M | -$216K | -$1.7M | -$1.7M | $12.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$62.9M | $2.3M | -$9.7M | -$21.3M | $3.8M | |
| Depreciation & Amoritzation | $6.9M | $4.6M | $3.8M | $3.8M | $3.8M | |
| Stock-Based Compensation | $2.9M | $5.5M | $4.5M | $1.4M | $1.9M | |
| Change in Accounts Receivable | $14.3M | -$9.1M | $10.3M | $7.6M | -$619K | |
| Change in Inventories | $406K | $50K | -- | -- | -- | |
| Cash From Operations | -$20M | $4.9M | -$8.8M | -$10.6M | $17.4M | |
| Capital Expenditures | $2.6M | $641K | $1.3M | $1.1M | $1.2M | |
| Cash Acquisitions | $815K | -$11.7M | -- | -- | -- | |
| Cash From Investing | -$1.7M | -$12.3M | -$1.3M | -$531K | -$635K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.2M | -- | $31M | $44M | $67M | |
| Long-Term Debt Repaid | -$20.5M | -$9.7M | -$26M | -$42.6M | -$73.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$215K | |
| Other Financing Activities | -- | -- | -- | -- | -$1.3M | |
| Cash From Financing | $24.3M | $2.6M | $4.2M | $9.1M | -$8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.6M | -$4.8M | -$5.9M | -$2M | $8.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$22.6M | $4.2M | -$10.1M | -$11.7M | $16.2M | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.3M | -$9.7M | -$21.3M | $3.8M | -- | |
| Depreciation & Amoritzation | $4.6M | $3.8M | $3.8M | $3.8M | -- | |
| Stock-Based Compensation | $5.5M | $4.5M | $1.4M | $1.9M | -- | |
| Change in Accounts Receivable | -$9.1M | $10.3M | $7.6M | -$619K | -- | |
| Change in Inventories | $50K | -- | -- | -- | -- | |
| Cash From Operations | $4.9M | -$8.8M | -$10.6M | $17.4M | -- | |
| Capital Expenditures | $641K | $1.3M | $1.1M | $1.2M | -- | |
| Cash Acquisitions | -$11.7M | -- | -- | -$0 | -- | |
| Cash From Investing | -$12.3M | -$1.3M | -$531K | -$635K | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $31M | $44M | $67M | -- | |
| Long-Term Debt Repaid | -$9.7M | -$26M | -$42.6M | -$73.6M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$215K | -- | |
| Other Financing Activities | -- | -$842K | -$769K | -$1.3M | -- | |
| Cash From Financing | $2.6M | $4.2M | $9.1M | -$8M | -- | |
| Beginning Cash (CF) | $65M | $43.1M | $33.4M | $17.6M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$4.8M | -$5.9M | -$2M | $8.8M | -- | |
| Ending Cash (CF) | $60.3M | $37.1M | $31.5M | $26.4M | -- | |
| Levered Free Cash Flow | $4.2M | -$10.1M | -$11.7M | $16.2M | -- | |
Get CNVS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CNVS
Sector
P/E ratio
72.89x
17.70x
PEG ratio
-0.26x
0.00x
P/B ratio
3.19x
1.49x
Price / LTM sales
1.42x
0.96x
Growth Metrics
CNVS
Sector
Revenue growth
206.87%
-0.53%
Earnings growth
--
-0.61%
Revenue (5-year growth)
14.75%
1.59%
Earnings forecast
--
$0.05
Profitability
CNVS
Sector
Profitability FY 2024
$39.4M
$256.3M
Return on invested capital
-29.81%
0.79%
Return on assets
-17.05%
0.12%
Return on equity
-35.17%
2.1%
Earnings Date
Last Earnings Date
Jun
27
Next Earnings Date
Aug
14
Estimated Next Earnings Date
Sep
26
Balance Sheet
CNVS
Sector
Total cash
$6.1M
$97.1M
Short term investments
--
$26.8M
Total assets
$72.5M
$827.5M
Long term debt
$3.8M
$44M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
